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According to the traditional understanding of cerebrospinal fluid (CSF) physiology, the majority of CSF is produced
by the choroid plexus, circulates through the ventricles, the cisterns, and the subarachnoid space to be absorbed
into the blood by the arachnoid villi. This review surveys key developments leading to the traditional concept.
Challenging this concept are novel insights utilizing molecular and cellular biology as well as neuroimaging, which
indicate that CSF physiology may be much more complex than previously believed. The CSF circulation comprises
not only a directed flow of CSF, but in addition a pulsatile to and fro movement throughout the entire brain with
local fluid exchange between blood, interstitial fluid, and CSF. Astrocytes, aquaporins, and other membrane
transporters are key elements in brain water and CSF homeostasis. A continuous bidirectional fluid exchange at the
blood brain barrier produces flow rates, which exceed the choroidal CSF production rate by far. The CSF circulation
around blood vessels penetrating from the subarachnoid space into the Virchow Robin spaces provides both a
drainage pathway for the clearance of waste molecules from the brain and a site for the interaction of the systemic
immune system with that of the brain. Important physiological functions, for example the regeneration of the brain
during sleep, may depend on CSF circulation.
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The anatomy of the cerebrospinal fluid (CSF) system in-
cludes the cerebral ventricles as well as the spinal and
brain subarachnoid spaces, cisterns and sulci. The trad-
itional understanding of CSF physiology assumes that 80%
of CSF is secreted by the choroid plexus into the ventricu-
lar cavities. Other structures, e.g. the brain parenchyma,
add the remaining 20%. The rate of CSF formation in
humans is 0.3 – 0.4 ml min−1, and the total CSF volume is
90 – 150 ml in adults. It is also believed that CSF circu-
lates through the ventricles, the cisterns, and the sub-
arachnoid space ultimately to be absorbed into the venous
blood at the level of the arachnoid villi. Minor portions of
CSF may be drained into the cervical lymphatics that
run via the perineural spaces of the cranial nerves.
Traditionally, the circulatory character of CSF flow is
accepted and coined as the “third circulation” (see for
example [1-5]).
The traditional understanding of CSF physiology is
mainly based on animal experimentation, which was criti-
cized as early as 1947. It was argued that neuropathological* Correspondence: thbrinker@gmail.com
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unless otherwise stated.observations fail to support the experimentally-based hy-
pothesis that the origin of the cerebrospinal fluid is largely
from the choroid plexus [6]. Recent research challenges
significant aspects of the classical model and the circula-
tory nature of the CSF flow has been questioned. Specific
aspects now being reconsidered include the rate and site
of CSF formation and absorption [7-10]. This review re-
examines key developments that have led to the tra-
ditional concept of CSF physiology and introduces new
findings that enhance our current understanding. Novel
insights from molecular and cellular biology as well as
neuroimaging research have shown that CSF physiology is
much more complex than previously recognized.Review
Traditional understanding of CSF physiology
CSF formation
Most CSF is formed in the cerebral ventricles. Possible
sites of origin include the choroid plexus, the ependyma,
and the parenchyma [2]. Anatomically, choroid plexus tis-
sue is floating in the cerebrospinal fluid of the lateral,
third, and fourth ventricles. This tissue is well perfused by
numerous villi, each having a central capillary with fenes-
trated endothelium. A single layer of cuboidal epitheliumLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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anatomy forms the blood CSF barrier characterized by
tight junctions at the apical end of the choroid epithelial
cells rather than at the capillary endothelium within each
villus [2,11,12].
Due to its glandular appearance and ventricular loca-
tion, the choroid plexus has been suggested to be the
major site of CSF secretion. This view was mainly based
upon the historical canine experiments of Dandy. In these
experiments the foramen of Monro was occluded and a
choroid plexectomy of one lateral ventricle was per-
formed. The authors reported collapse of the ventricle
without choroid plexus and dilatation of the other ven-
tricle [13]. They concluded: “From these experiments we
have the absolute proof that cerebrospinal fluid is formed
from the choroid plexus. Simultaneously it was proven
that the ependyma lining the ventricles is not concerned
in the production of cerebrospinal fluid” [14]. Interes-
tingly, the experiments of Dandy were based upon ob-
servations from only a single dog [1]. Furthermore, the
experiments could not be reproduced by others [15-17].
There were two other sets of experiments that were
thought to be “crucial” in support of Dandy’s thesis [1]:
First, the hematocrit of the choroid plexus blood was
found to be 1.15 times greater than of that of the systemic
arterial blood. From this value and the estimated arterial
blood flow through the choroid plexus, a CSF secretion
rate was calculated that came very close to the estimated
rate of total CSF absorption [18]. Second, these findings
were substantiated by concordance with experiments in
which the CSF production rate was assessed in the iso-
lated and extracorporally-perfused choroid plexus [19-22].
These experiments, however, were criticized because of
inherent large errors possible in the experimental tech-
nique since the various preparations all required consider-
able operative manipulations [1,2,11]. Furthermore, other
experimental studies, including those with radioactive
water provided evidence that at least some CSF must
come from a source other than the choroid plexus, pre-
sumably the brain tissue itself [23-25]. From perfusion
studies performed on isolated regions of the ependymal
surface it was calculated that nearly 30% of the total CSF
production may come from the ependyma [26]. An even
higher rate of ependymal fluid secretion was derived from
experiments investigating spinal cord ependyma [27].
Again, these experiments were criticized because of the
“drastic experimental procedures” used. It was concluded
that “it may be wise to reserve final judgment on this
question” [11]. The capillary-astrocyte complex of the
blood–brain barrier (BBB) has been implicated as an
active producer of brain interstitial fluid (ISF). The ISF
secreted at the blood–brain barrier is coupled with shifts
of extracellular fluid between brain and CSF, eventually
leading to the net formation of CSF [28,29]. The rate ofISF formation was estimated from the clearance rate of
tracer substances, which were injected into the brain
parenchyma. It was assumed that the rate of clearance
provides an estimate of the rate of ISF secretion at the
blood–brain barrier. The calculated rate of formation was
substantially lower (1/100 when normalized for barrier
surface area) than the choroid plexus production rate [30].
Accordingly, even a recent review concluded that “the
working hypothesis that the BBB is a fluid generator,
although attractive, needs substantiation” [4].
CSF absorption
Historically, the absorption of CSF into the circulating
blood is most notable across the arachnoid villi [3,31,32].
It was stated: “From a purely anatomical point of view,
these arachnoid villi are obvious regions for the drainage
of CSF into the vascular system…” (page 486 in [33]). The
notion of the arachnoid villi being the major site of CSF
absorption is actually based on the early experiments of
Key and Retzius who injected colored gelatin into the CSF
space of human cadavers. They reported the distribution
of the dye throughout the entire CSF system and its pas-
sage across the arachnoid villi into the venous sinuses
[34]. However, their results were questioned since the dye
was injected at a pressure of up to 60 mmHg. It was sug-
gested that the high pressure during the dye injection
could cause rupture of the arachnoid villi and absorption
into the sinuses [35]. Therefore, Weed performed dye in-
jection experiments at pressures of only 9–13 mmHg that
also attempted to determine whether or not the injected
dye particles themselves could obstruct the normal drain-
age pathways. Isotonic solutions of non-toxic dyes (am-
monium citrate and potassium ferrocyanide) were infused
that precipitated granules of Prussian blue before the ani-
mals were intravitally fixed with acidified formalin. Weed
reported the distribution of the dye particles throughout
the entire CSF space, filling the arachnoid villi along the
sagittal sinus, eventually invading the dural wall of the
sinus. Notably, only some granular material was found in
the lumen of the sinus [35,36]. The authors also stated as
another important result: “No evidence has been afforded
in our observations of the escape of cerebrospinal fluid
into cerebral veins or capillaries” [37]. Weed’s findings
formed the basis for the principal understanding of CSF
absorption, accepted by the majority of researchers today.
Weed performed numerous pilot experiments in his effort
to identify a dye solution that was best suited for his stu-
dies: “Many solutions were tried, but all proved unsatis-
factory because of their toxicity or their diffuse tissue
staining” [36]. One could argue, therefore, that Weed in-
advertently excluded those solutions in which the absorp-
tion of CSF throughout the entire brain parenchyma
would have been the result. Electron microscopy studies
performed on arachnoid villi revealed a pressure-sensitive
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and allow for the transcellular bulk transport of fluid
[38,39]. Extracorporal perfusion of excised dura demon-
strated the passage of particles up to the size of erythro-
cytes [40].
Considerable portions of CSF may be absorbed into
the cervical lymphatics [2]. The perineural subarachnoid
space of cranial nerves, which is connected to the cranial
CSF space, was suggested as a pathway for the drainage
of CSF into the lymphatics of the extracranial soft tissue
at the skull base [2]. Though it is obvious that CSF
drains into the lymphatics, the physiological significance
of this CSF absorption route is still a matter of debate.
Five hours after the injection of albumin dye into the
CSF space of rabbits only 5% is typically seen draining
into the cervical lymph nodes [41]. This finding led to
the conclusion that only a small fraction of CSF drains
via the lymphatic channels. However, in the same period
of time only 14% of the injected dye was found in the
blood, revealing that lymphatic channels contributed to
26% of the tagged protein that had left the central ner-
vous system and entered the blood stream [2]. Following
the infusion of iodine-labeled serum human albumin
into sheep, it was determined that 40–48% of total vo-
lume of CSF is absorbed from the cranial compartment
by extracranial lymphatics [42]. A lymphatic drainage
fraction of 50% was estimated from the injection of
radioiodinated albumin (RISA) into the brain of rabbits.
Interestingly much RISA was drained via the cerebral
perivascular spaces as well as by the passage from the
subarachnoid space of olfactory lobes into the submuco-
sal spaces of the nose (and thus to the lymphatics) [43].
Intravital microscopy of the exposed cervical lymph
nodes during the cisternal infusion of ink revealed that
particle movement was dependent on the respiratory
cycle: during inspiration the speed of particle movement
was 10–20 mm s−1, while no movement was observed
during the expiration phase [44]. It is important to note
that the CSF and ISF spaces communicate with the
cervical lymphatics via two anatomically different routes,
i.e. the perineural subarachnoid space of cranial nerves
and a “prelymphatic” pathway along the arterioles
and arteries of the brain (see discussion below, reviewed
by [45]).
Extracranial organs feature fluid exchange across the
capillary bed that is driven by hydrodynamic and os-
motic pressure gradients. However, absorption of CSF
into cerebral capillaries has been disputed because it was
thought that the absorption of CSF is not dependent on
osmotic forces. This notion was based on experiments
in which dextran solutions of different osmolality were
infused into the ventricles of cats at a constant pressure
of 27 mmHg. The measured infusion rate, which should
equal the CSF absorption rate, decreased by the sameextent. The decrease of the absorption rate was ex-
plained by the increased CSF viscosity [33]. Interestingly,
a more recent animal study failed to reproduce these
earlier experiments, since it was shown that 3H2O from
the bloodstream enters osmotically loaded cerebrospinal
fluid significantly faster [46]. Since, historically, osmo-
lality was assumed to not be relevant for CSF absorption,
hydrodynamic pressure gradients would be the only
driving forces for CSF drainage into the brain capillaries
and post-capillary venules. It was also assumed that any
absorption would require a CSF pressure higher than
the intravascular pressure and that this would cause the
collapse of the vessels and prevent absorption of CSF
[2,47]. These statements from the 1970s and 1980s were
actually defining the understanding of CSF physiology
for decades until BBB and aquaporin (AQP) studies
clearly indicated the involvement of osmotic forces in
brain water homeostasis (for discussion see below).
Assessment of CSF formation and absorption rate
In 1931, Masserman calculated the rate of CSF forma-
tion in patients by measuring the time needed for the
CSF pressure to return to its initial level following drai-
nage of a standard volume of CSF by lumbar puncture
[48]. After drainage of 20 to 35 mL of CSF, pressure was
restored at a rate of about 0.32 ml min−1. The validity of
results obtained in this way was criticized because the
Masserman technique assumes that neither formation
nor absorption rates are changed by alterations in pres-
sure. However, the absorption of CSF varies greatly with
changes in intracranial pressure [49,50]. Modifications of
the Masserman technique applied sophisticated infusion
and drainage protocols, which recorded and controlled
the CSF pressure during the measurement period (see
for example [51]). Despite numerous research efforts,
more sophisticated experimental protocols did not yield
CSF formation rates that differed from earlier work.
The ventriculo-cisternal perfusion (“Pappenheimer”)
technique represents a more quantitative approach for
the assessment of CSF formation rate. Inulin or other
macromolecules, which pass through the ventricular
space without being absorbed, are infused at a constant
rate into the cerebral ventricles. CSF formation is cal-
culated from the measurement of the extraventricular
(cisternal or spinal) CSF concentration of inulin. It is as-
sumed that any dilution of inulin between the inflow
cannula and outflow cannula results from the admixture
of freshly formed CSF. In addition, the test procedure
allows for the calculation of the CSF absorption rate
from the clearance of inulin at the extraventricular site
(in animals the cisterna magna, in man the lumbar
space) [49]. An important disadvantage was that the pro-
cedure was difficult to apply in clinical settings because
of its invasiveness: The hour long infusion required both
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both infusion rate and infused volume exceeded the
physiological range of CSF flow by far. Despite these ob-
stacles, clinical measurements were performed in brain
tumor patients who received ventricular catheters for
chemotherapy purposes: In patients (9–61 years old) the
average flow rate was 0.37 ml min−1, the maximum ab-
sorption capacity was 1.3 ml.min−1 [52]. These results
were confirmed in children with brain tumors [53].
Furthermore, similar data are available from hydro-
cephalus patients [54]. Though more precise, the ventri-
culocisternal or ventriculolumbar perfusion techniques
yielded results remarkably close to those assessed by
the Masserman technique [2]. Findings from both the
Masserman and the Pappenheimer techniques were sup-
ported by neuroradiological investigations applying serial
CT scans to assess the ventricular washout of metriza-
mide, a water soluble contrast media. The rate of right
lateral ventricular CSF formation ranged from 0.0622 to
0.103 ml min−1 [55,56]. Hence, the assessment of the
CSF formation and absorption rates remains a matter of
debate even today. It has been suggested that a method
that is less invasive than the Pappenheimer method
(ventriculo-cisternal perfusion) and more reliable than
the Masserman method is sorely needed [50].
CSF circulation
The concept of the “third circulation” suggesting that
CSF flows through the ventricles, cisterns and subarach-
noid space (SAS) and is reabsorbed into the blood at the
arachnoid villi, was introduced by Cushing in 1926
[57,58]. This notion was a radical departure from the
contemporary view that the CSF moved by ebb and flow
[1]. Since Cushing, the circulatory, bulk flow character
of the CSF system has remained unquestioned by the
majority of researchers. Even recent reviews assume a
directed CSF circulation through the ventricles and the
subarachnoid space toward the arachnoid villi [1,5,32].
Nevertheless, as will be discussed below, this under-
standing of CSF circulation appears to be a rough sim-
plification of a much more complicated situation. This
especially holds true for the circulation of CSF along the
Virchow–Robin spaces (VRS). The current classical view
assumes that CSF flow along the VRS is slow and
physiologically not important [4,5].
Virchow-Robin space circulation
Anatomically the VRS refers to a histologically-defined
space, which surrounds blood vessels (arterioles and
venules) when penetrating from the subarachnoid space
into the brain tissue. Originally, it was thought that the
VRS is connected to the subarachnoid space, allowing
for a free fluid communication. It was suggested that
interstitial fluid may be outwardly drained along thesepathways into the SAS and eventually towards the arach-
noid villi [35]. Later this concept was questioned on the
basis of light microscopic examinations, which depicted
perivascular spaces as cul-de-sacs, open to the subarach-
noid space but closed towards the parenchyma and
therefore not a channel for flow [59]. The first system-
atic electron microscopic study of blood vessels entering
the cerebral cortex confirmed this view. In addition it
was reported that small arterioles entering the cortex
carry with them (to the point at which they become ca-
pillaries) an extension of the subarachnoid space [60].
Actually, these findings, showing the obliteration of the
VRS at the capillary bed, led to the rejection of the earl-
ier theories on the existence of a perivascular CSF circu-
lation. As discussed by others [61], these morphological
findings eventually supported the general belief that the
interstitial fluid (ISF) is stagnant in the central nervous
system.
The current understanding of the microscopic anat-
omy of the VRS is more complex (Figure 1). Actually, its
fine structure is built upon endothelial, pial, and glial cell
layers, each of them delineated by distinct basement
membranes [62-64]. The glial membrane (glia limitans)
covering the brain parenchyma forms the outer wall of
the VRS [65]. At the capillary bed, the basement mem-
brane of the glia fuses with the outer vascular membrane
thereby occluding the Virchow-Robin space [66,67]. Ar-
terial and venous vessels running within the cortical sub-
arachnoid space are covered with a pial cell layer, which
ensheaths the vessels. The pial sheath creates a space
next to the vessel wall, which is referred to as perivascu-
lar space (PVS) [68]. At the site of the entrance of the
cortical vessels into the VRS, their pial sheath joins with
the pial cell layer covering the brain surface forming a
funnel like structure, which accompanies the vessels into
the VRS though for a short distance only [69,70]. How-
ever, the pial sheath of the arterial, but not venous, ves-
sels extends into the VRS. Near the capillary bed, the
pial sheath becomes more and more fenestrated and
leaky [68]. It is important to note that the nomenclature
is not used consistently. Some authors use the terms
“Virchow Robin space” and “perivascular space” as syno-
nyms [71], while others use the terms to name different
spaces as discussed above [72].
Ultrastructural electron microscopic studies agree that
pial membranes separate the VRS from the cortical sub-
arachnoid space [65,68,70]. Since electron microscopy of
human brain specimens shows that the VRS and the
PVS are collapsed [68], it is a matter of debate whether
these histologically-characterized compartments are
actually open or just potential spaces. However, studies
in rodents have demonstrated the VRS filled with fluid,
electron microscopic dense material [70], macrophages
and other blood born inflammatory cells [64,67].
Figure 2 Diagram representing fluid movements at the
Virchow Robin space. The complex anatomical structure of the
Virchow Robin space (VRS) allows a bidirectional fluid exchange
between the VRS and both the brain extracellular space (ECS) and
the subarachnoid CSF space (blue arrows). Glial (blue lines) and pial
(yellow lines) cell membranes enclose the VRS and control fluid
exchange. Note, that it is a matter of debate whether the VRS
represents an open fluid fill space (see text for discussion). Both
experimental and clinical evidence indicate the existence of a
pathway along the basement membranes of capillaries, arterioles,
and arteries for the drainage of ISF and solutes into the lymphatic
system (red lines and green arrows). It is unclear, whether the
subpial perivascular spaces around arteries and veins (light blue)
serve as additional drainage pathways. Also, the proposed
glymphatic pathway connecting the arterial and venous VRS with
the venous perivascular space (black arrows) is still a matter of
debate. A: artery, V: vein, C: capillary, VRS: Virchow Robin space, SAS:
subarachnoid space.
Figure 1 Morphology of Virchow Robin and perivascular
spaces. Delineated by basal membranes of glia, pia and
endothelium, the Virchow Robin space (VRS) depicts the space
surrounding vessels penetrating into the parenchyma. The VRS is
obliterated at the capillaries where the basement membranes of glia
and endothelium join. The complex pial architecture may be
understood as an invagination of both cortical and vessel pia into
the VRS. The pial funnel is not a regular finding. The pial sheath
around arteries extends into the VRS, but becomes more fenestrated
and eventually disappears at the precapillary section of the vessel.
Unlike arteries (as shown in this figure), veins do not possess a pial
sheath inside the VRS. ISF may drain by way of an intramural
pathway along the basement membranes of capillaries and
arterioles into the lymphatics at the base of the skull (green arrows).
It should be noted that the figure does not depict the recently
suggested periarterial flow from the SAS into the parenchyma and
an outward flow into the cervical lymphatics along the veins
(for discussion see text “Current research”). Also, it is still a matter of
debate whether the Virchow Robin space, extending between the
outer basement membrane of the vessel and the glia, represents a
fluid-filled open space (see text). VRS: Virchow Robin space, SAS:
subarachnoid space.
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discrepancy: rodent brains undergo intra-vital perfusion
fixation, while the studies in man have to rely on speci-
mens, which are fixed extra-corporally.
Although pial cell layers obviously separate the VRS
from the cortical subarachnoid space, physiologically
there is strong evidence indicating that fluid circulates
along the VRS (Figure 2). Following the injection of
horseradish peroxidase (HRP) into the lateral ventricles
or subarachnoid space of anesthetized cats and dogs,
light microscopic examination of serial brain sections
has been performed utilizing a sensitive histochemical
technique (tetramethylbenzidine incubation) [73]. The
authors reported the distribution of tracer reaction pro-
duct within the VRS and along the basal laminae around
capillaries. The influx into these spaces was very rapidsince the intraparenchymal microvasculature was clearly
outlined 6 min after the infusion of HRP. Electron micros-
copy of sections incubated after 10 or 20 min of HRP
circulation confirmed the paravascular location of the re-
action product, which was also dispersed throughout the
extracellular spaces (ECS) of the adjacent parenchyma.
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by halting or diminishing the pulsations of the cerebral
arteries by aortic occlusion or by partial ligation of the
brachiocephalic artery. However, it should be noted that
others were not able to reproduce these findings; Krisch
et al. found no spread of HRP from the subarachnoid
space into the VRS [70]. Also, another study reported that
following microinjection into the VRS or the subarachnoid
space of rats, tracers (e.g. India ink, albumin labeled with
colloidal gold, Evans blue, rhodamine) remained largely in
the VRS, the cortical subpial space and the core of sub-
arachnoid trabeculae. Nevertheless, bulk flow of fluid
within the VRS, around both arteries and veins, was sug-
gested from video-densitometric measurements of fluores-
cently labeled albumin. However, the observed flow was
slow and its direction varied in an unpredictable way [71].
Furthermore, it was shown that, following intracerebral
injection, India ink particles concentrated in the VRS, but
were then rapidly ingested by perivascular cells. Notably,
very little movement of carbon-labeled perivascular cells
and perivascular macrophages was seen after 2 years [74].
Since there is obviously at least some circulation of CSF
into and out of the VRS, it raises the question how fluid
and tracers could cross the pial membranes separating the
VRS from the subarachnoid space. Ultrastructure studies
have depicted the pial barrier as a delicate, sometimes
single-cell layered structure [75]. There are considerable
species differences: in the mouse the pial layer was found
to be extremely thin, while in man its structure was sig-
nificantly thicker [76]. Notably, in man the pial barrier
was still described as a delicate yet apparently continuous
layer of cells, which were joined by desmosomes and gap
junctions but had no obvious tight junctions [77]. Accor-
ding to such morphological studies, it was recognized that
the pia is not impermeable to fluids [61]. Since, in a simi-
lar fashion, the ependymal cell layers covering the inner
(ventricular) surfaces of the brain are not connected by
tight junctions [78], it was suggested that “CSF communi-
cates with the ISF across the inner (ependymal) and outer
(pial) surfaces of the brain” [61]. If one assumes that the
flow within the VRS depends on the pulsatility of the
arteries [73,79], hydrostatic forces may drive fluids and
solutes across the pial membranes. However, while the
VRS basically allows for the bi-directional exchange bet-
ween CSF and ISF, no quantitative data are available that
describe the extent and kinetics of such fluid movements.
Although it has been shown that pial membranes between
the PVS and the SAS could prevent the exchange of larger
molecules, since tracer, following intraparenchymal injec-
tion, accumulated within the PVS but was not distributed
into the cisternal CSF [80]. This observation is supported
by clinical findings that following aneurysmal rupture in
man, red blood cells are confined to the subarachnoid
space, and do not enter the VRS [76].It has also been shown both experimentally and clini-
cally that the PVS and possibly more importantly intra-
mural pathways between the basement membranes of
the wall of arterioles and arteries provide drainage for
the ISF and waste molecules of the brain. There is
experimental evidence that the para-arterial drainage
pathways are connected to the lymphatics of the exterior
skull base [81,82]. Actually, solutes and fluid may be
drained along the arteries from the brain interstitium
via the VRS into the cervical lymphatics [81,83],
reviewed by Weller [45]. Supporting this notion are the
immunohistochemical and confocal microscopic obser-
vations that soluble fluorescent tracers (3 kD dextran or
40 kD ovalbumin) move from the brain parenchyma
along the basement membranes of capillaries and arteries
following its injection of into the corpus striatum of mice.
This pathway may not serve for the transport of particles
or cells, since fluospheres (diameter 0.02 μm and 1.0 μm)
did not leave the brain but expanded the periarterial
spaces and were locally ingested by macrophages. Clear-
ance of solutes along this pathway could be prevented by
cardiac arrest [83]. The finding that macromolecules may
be drained from the brain via perivascular or intramural
transport led to the notion that vessels and their pial
sheaths act as ‘lymphatics of the brain’. These findings are
clinically significant since based upon observations in pa-
tients with cerebral amyloid angiopathy, beta-amyloid is
deposited in the vascular wall of arterioles and arteries.
The deposition of insoluble amyloid may obstruct this
drainage pathway and therefore impede the elimination of
beta-amyloid and interstitial fluid from the brain in
Alzheimer’s disease [82,84]. Interestingly, the extent of
amyloid deposition is so prominent that it was suggested
as a natural tracer for the peri-arterial drainage pathways
[83]. The peri-arterial drainage of fluids and solutes has
important implications not only in neurodegenerative
diseases, but in addition in immunological CNS dis-
eases, see for comprehensive reviews [45,85,86]. Simi-
lar to arteries, veins within the subarachnoid space
possess a pial sheath forming a PVS [64]. As com-
pared to arteries, it is less clear whether venous peri-
vascular pathways serve as a drainage pathway for ISF
and interstitial solutes. Notably, injections of tracers
into the brain revealed no drainage along peri-venous
channels unless there is disruption of flow in cerebral
amyloid angiopathy when some tracer enter the peri-
venous spaces [87]. However, recent findings [88] in-
dicate a more significant contribution of the venous
perivascular route for the drainage of ISF and solutes
(see discussion below).
Interstitial fluid movement
Traditionally, movement of fluids through the brain inter-
stitial space has been attributed to diffusional processes
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and tortuosity of the extracellular space of the brain
(reviewed by [92] ). Today, it is commonly accepted that
“the narrow spaces between cells within the neuropil are
likely to be too small to permit significant bulk flow” [29].
A recent review discusses important clinical implications
regarding CNS drug delivery [93]. As commented by
others [45,94], our current understanding includes bulk
flow mechanisms for the movement and drainage of ISF
along white matter tracts and the perivascular spaces.
Considering the cellular architecture of pia and ependyma,
it also accepted that these cellular layers represent a diffu-
sional barrier, which actually provides a communication
between ISF and CSF [61]. Experimental evidence for the
existence of bulk flow mechanisms was found after micro-
injection of tracer into the brain. Morphological studies
revealed the VRS and the perivascular spaces as channels
for fluid transport, but also revealed additional spaces bet-
ween fiber tracts in white matter and the subependymal
layer of the ventricle. Analysis of the kinetics of removal
of three radiolabeled tracers from brain tissue (e.g. poly-
ethylene glycols: 0.9 and 4 kD and albumin: 69 kD), pro-
vided evidence for the convection of ISF. These three test
compounds differ in their diffusion coefficient by up to a
factor of five but were cleared from brain according to a
single exponential rate constant. This is consistent with
removal by convection from a well-mixed compartment.
For different regions of the brains of rats and rabbits, the
ISF flow rate was estimated between 0.11 and 0.29 μl g
brain−1 min−1 [30,61], reviewed by [29]. Very recently it
has been shown that astrocyte water transporters, i.e.
aquaporin-4 (AQP4), contribute to interstitial brain water
movement: in transgenic animals lacking AQP4, the inter-
stitial drainage of tracer injected into brain parenchyma
was significantly reduced [95].
Towards a molecular understanding of brain water fluxes
The discovery of water transporters (‘water channels’)
located at the end-feet processes of astrocytes has de-
cisively improved our understanding of the physiology of
the blood brain barrier and has led to the concept that
large water fluxes take place continuously between the
different compartments of the brain, i.e. the blood, CSF
and ISF (reviewed in [96-98]). Interestingly, such exten-
sive water movements were indicated by earlier radio-
tracer experiments. For example in 1952, following the
intravenous injection of deuterium oxide a rapid distri-
bution throughout all brain compartments was reported
[99]. These data demonstrated water fluxes that greatly
exceeded the contemporary estimated rates of CSF and
ISF flow. As a result, the significance of this work was
not fully appreciated. Recently the original data on the
deuterium oxide half-life in different brain compart-
ments has been used to calculate the respective CSFfluxes by applying MRI-based volume assessments of the
ventricles, the subarachnoid space and the spinal CSF
spaces. As result, CSF fluxes of more than 22 ml min−1
and a CSF turnover rate of more than 140 times a day
were calculated. This is far greater than the traditional
views of CSF physiology [100]. Of note, the permeability
of deuterium oxide through AQP1 [101] and AQP4
[102] is similar to that of water.
Choroid plexus
CSF formation at the choroid plexus occurs in two stages:
passive filtration of fluid across the highly permeable
capillary endothelium and a regulated secretion across the
single-layered choroidal epithelium. The choroidal epi-
thelium forms a fluid barrier since tight junctions are
expressed at the apical, CSF facing, cell membrane
[103]. The rate of choroidal CSF formation is rather
insensitive to osmotic and hydrostatic pressure changes in
the CSF and therefore relatively independent of changes
in intracranial pressure and plasma osmolarity. Hence,
water transport across the choroid plexus epithelium can-
not be explained simply by an osmotic mechanism
(discussed in detail in [96]). Today there is agreement that
choroidal CSF production is controlled by membrane
transporters within the epithelium. Different transporters
are expressed at the basolateral (plasma facing) and apical
(CSF facing) membranes. Due to its high AQP1 expres-
sion, the apical membrane has high water permeability.
In contrast to this, the basolateral membrane lacks
significant AQP1 expression [104]. At the apical mem-
brane a K+/Cl− cotransporter is co-localized with the
Na+/K+ -ATPase. Together, these transporters expel water
from the cell into the CSF space. Little is known about the
water transport at the basolateral membrane. There is a
K+/Cl− cotransporter, but its role is not yet well under-
stood [96]. The molecular mechanisms of choroidal CSF
production are comprehensively reviewed in [96,105,106].
Blood brain barrier
Traditionally the properties of the blood–brain barrier
(BBB) are considered to be those of the capillary endo-
thelium in brain. This endothelium contrasts with that
elsewhere in the body by being sealed with tight junc-
tions, having a high electrical resistance and a low per-
meability to polar solutes [89]. Early research unveiled
ion channels and transporters capable of providing a net
secretion of fluid, driven by Na+/K+ - ATPase, on the
brain side of the barrier. Accordingly, the BBB was pro-
posed as a secretory endothelium, which produces ISF
[107]. Recent research has unveiled that the ‘barrier’
function of the BBB is in fact the result of highly regu-
lated and complex cellular and molecular transport pro-
cesses, which allow for the transport of water, solutes,
larger molecules and even cells (reviewed by [108-110]).
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improved by the discovery that cells surrounding the
capillaries can control and modulate BBB functions. Con-
sidering the involvement of astrocytes, pericytes, microglia
and even neurons, the BBB is better described as a ‘neuro-
vascular unit’ [111]. The role of astrocytes is of utmost
interest with respect to CSF physiology, since astrocyte
end-feet have been shown to cover the entire capillary sur-
face, leaving intercellular clefts of less than 20 nm [112].
The astrocytes, therefore, form an additional barrier sur-
rounding the cerebral capillaries [98]. The role of astro-
cytes in brain water homeostasis is strongly supported by
the finding that water transporting pores (i.e. the aqua-
porins) are localized in the end feet [113,114], reviewed by
[97]. It is also important to recognize that contrary to
earlier assumptions, the endothelial barrier carries no
AQP4 transporters [115]. Instead, water may cross the
endothelium by diffusion, vesicular transport and, even
against osmotic gradients, by means of co-transport with
ions and glucose (reviewed in [96]).
Aquaporins and other modes of water transport
The physiology of aquaporins (AQPs) and transpor-
ters in the brain has been comprehensively reviewed
[96,98,116-118]. Here those aspects are discussed, which
are relevant for the understanding of CSF circulation.
Basically, in response to both passive osmotic and hy-
draulic pressure gradients, AQPs can transport water,
solutes, and ions bi-directionally across a cell membrane.
In comparison to diffusional transport, AQPs have sig-
nificant biophysical differences. Diffusion is non-specific
and low-capacity movement, whereas water channels
like the AQPs provide rapid transport and have both a
high capacity and a great selectivity for the molecules
being transported [119]. As discussed below, that may
be especially important for fluid exchange between
ISF and CSF. More recent data in rodents have de-
monstrated that the precise dynamics of the astroglia-
mediated brain water regulation of the CNS is dependent
on the interactions between water channels and ion chan-
nels. Their anchoring by other proteins allows for the for-
mation of macromolecular complexes in specific cellular
domains (reviewed in [120]).
Currently, at least 14 different aquaporins have been
identified [97,117]. At least six have been reported in the
brain [121,122]: AQP 1, 4, 5 (specifically water permeable),
AQP3 and 9 (permeable for water and small solutes) and
AQP8 (permeable for ions) [116]. AQP4 is implicated in
the formation/resolution of brain edema and in the clea-
rance of K+ released during neuronal activity; AQP1 plays
a role in cerebrospinal fluid (CSF) formation, and AQP9
may play a role in energy metabolism [97]. Positron emis-
sion tomography techniques for imaging of AQP4 in
the human brain are currently being developed [123].Structural and functional data suggests that the perme-
ability of AQP channels can be regulated and that it might
also be affected in brain pathologies (reviewed by
[116,124]). As a result of the dynamic regulation, AQP
channel permeability or AQP channel subcellular loca-
lization may change within seconds or minutes leading to
immediate changes in the membrane permeability. Long-
term regulation is mediated by changes in AQP mRNA
and/or protein synthesis and/or degradation rate. These
changes will alter AQP expression within hours or days.
AQPs may be regulated under pathological conditions:
For example AQP1 and AQP4 are strongly upregulated in
brain tumors and in injured brain tissue [116], AQP5 is
down-regulated during ischemia but up-regulated follo-
wing brain injury [121].
Notably, AQP1 is expressed in vascular endothelial cells
throughout the body but is absent in the cerebrovascular
endothelium, except in the circumventricular organs
[125]. As already discussed AQP1 is found in the
ventricular-facing cell plasma membrane of choroid
plexus epithelial cells suggesting a role for this channel in
CSF secretion. In AQP1-null mice, CSF production was
20% less than in wild-type mice (0.38 ± 0.02 vs. 0.30 ±
0.01 μl min−1). Accordingly it was discussed that AQP1-
facilitated transcellular water transport accounts for only
part of the total choroidal CSF production. As a more
controversial possibility, it was suggested that the choroid
plexus may not be the principal site of CSF production
and that extrachoroidal CSF production by the brain
parenchyma may be more important [126,127]. The latter
notion is supported by the observation that following its
intravenous application, the penetration and steady con-
centration of H2
17O is significantly reduced in ventricular
CSF in AQP4 but not in AQP1 knockout mice. The
authors concluded that AQP4 is more important for CSF
production than AQP1 [122,128].
AQP4 is strongly expressed in astrocyte foot processes
at the BBB, glia limitans of brain surface and VRS, as
well as ventricular ependymal cells and subependymal
astrocytes. Actually, it is expressed at all borders bet-
ween brain parenchyma and major fluid compartments
[97,113,114]. Therefore, the earlier view of exchange of
ISF and CSF across ependymal and glial cell layers
[129] may be in fact aquaporin-mediated water transport
across these membranes [130]. AQP4 is also localized in
astrocyte end feet at the perisynaptic spaces of neurons
and is found in the olfactory epithelium [97]. The pre-
cise subcellular distribution of AQP4, i.e. in the astrocyte
foot processes, is regulated by its association with the
dystrophin glycoprotein complex, including dystrophin,
beta-dystroglycan, and syntrophin [131,132]. In mice
lacking alpha-syntrophin, astrocyte AQP4 is displaced,
being markedly reduced in the end feet membranes adja-
cent to the blood vessels in cerebellum and cerebral
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branes directly facing the neuropil [131]. Others reported
that the deletion of alpha-syntrophin causes a 50% loss of
AQP4 from the cortical membrane as compared with a
90% loss at the perivascular membrane [133]. A similar ef-
fect on AQP4 localization is observed in dystrophin-null
mice [134]. AQP4 has been suggested to interact with the
inwardly rectifying K+ channel Kir4.1 [135]. Since Kir4.1 is
also associated with the dystrophin glycoprotein complex
the pattern of the subcellular distribution of AQP4 and
Kir4.1 in astrocytes is very similar [136].
AQP4 is involved in water movements under patho-
logical conditions (see for details [97,125,137,138]). There
is agreement that AQP4-null mice have reduced brain
swelling and improved neurological outcome in models of
(cellular) cytotoxic cerebral edema including water intoxi-
cation, focal cerebral ischemia, and bacterial meningitis.
However, brain swelling and clinical outcome are worse in
AQP4-null mice in models causing a disruption of the
BBB and consecutive vasogenic edema. Impairment of
AQP4-dependent brain water clearance was suggested as
the mechanism of injury in cortical freeze-injury, brain
tumor, brain abscess and hydrocephalus [125]. In hydro-
cephalus produced by cisternal kaolin injection, AQP4-
null mice demonstrated ventricular dilation and raised
intracranial pressure, which were both significantly greater
when compared to wild-type mice [139].
It is a matter of ongoing research whether AQP4-
mediated brain water movement is relevant under physio-
logical conditions. Considering only the pattern of AQP4
expression at the borders between the brain and CSF com-
partments, it has been suggested that AQP4 facilitates or
controls the flow of water into and out of the brain [98].
However, how aquaporins modulate CSF/ISF circulation
and whether they impact fluid flow in extracellular path-
ways within the tightly packed neuropil is only poorly
understood. Since AQP4 is also expressed at astrocytic
end feet near the perisynaptic spaces, a putative role for
astrocytes and AQP4 for K+ homeostasis during neuronal
activity has been postulated (reviewed by [97]). AQP4
deletion is associated with a sevenfold reduction in cell
plasma membrane water permeability in cultured astro-
cytes [140] and a tenfold reduction in BBB water perme-
ability in mouse brain [141]. However, AQP4 deletion was
found to have little impact on CSF dynamics (reviewed by
[106]). In AQP4-null mice unaltered intracranial pres-
sure and compliance were found [142]. Furthermore, no
changes in ventricular volume or anatomical features
of two different AQP4-null mice strains were reported
[143]. However, others observed smaller ventricular sizes,
reduced CSF production and increased brain water in
AQP4-null mice [144]. Considering that the deletion of
AQP4 has only little or modest in vivo effects, the current
view is that, under normal physiological conditions, AQP4is not needed for relatively slow water movement condi-
tions [97]. However, the minimal impact of AQP4 deletion
on CSF physiology may be explained by the fact that
AQP4 deletion reduces both ISF/CSF formation and
absorption. Mice in which a conditional knockout was
driven by the glial fibrillary acidic protein promoter,
showed increased basal brain water content. In these
animals the extracerebral AQP4 function is preserved but
AQP4 is eliminated in cells that express the GFAP pro-
moter, i.e., astrocytes and ependyma. After systemic hypo-
osmotic stress by intraperitoneal water injection, those
mice showed a 31% reduction in brain water uptake. It
was concluded that the glial covering of the neurovascular
unit limits the rate of brain water influx as well as the
efflux [115].
It is now widely accepted that water moves across the
endothelium by simple diffusion and vesicular transport,
and across the astrocyte foot process primarily through
AQP4 channels (reviewed by [98]). In addition, a variety
of endothelial water-transport proteins expressed in one
or both of the cell membranes (luminal or apical), provide
co-transport of water along with their substrates even
independently of osmotic gradients. Especially the glucose
transporter GLUT1 and the Na+/K+/2Cl− cotransporter,
NKCC1, may contribute significantly to transendothelial
water transport (reviewed by [96]). The identification of
non-aquaporin water transporters located at the endothe-
lium was a major contribution to the understanding of
water transport across the neurovascular unit (not just
the astrocyte or endothelial barrier). It is important to
recognize that all these transport mechanism are bi-
directional and represent a dynamic process. This implies
that large water fluxes may take place continuously, al-
though the net flow may be small. This would explain the
fast and extensive passage of deuterium oxide from blood
to brain [99]. As a process independent of net flow, the
finding could be understood as a result of a dynamic bi-
directional mixing of water between the blood, ISF and
the CSF compartments. The bidirectional transport could
also generate net-flux. Actually, the neurovascular unit
may not only be involved in the production but also in the
absorption of CSF and ISF. This is suggested by recent
experiments in which tritiated water was infused into the
ventricle of cats. During a three-hour infusion, the con-
centration in blood sampled from the cerebral venous
sinuses rapidly increased up to 5 times higher than in
samples of cisternal CSF and arterial blood. However,
following the infusion of 3H-inulin, the cisternal concen-
tration increased sharply during the observation period of
three hours. At the same time venous and arterial concen-
trations were near background activity. It was concluded
that 3H-water, but not 3H-inulin, is absorbed from brain
ventricles into periventricular capillaries, which eventually
drain in the venous sinuses [145]. Figures 2 and 3
Figure 3 Diagram of the CSF “Circulation”. This diagram
summarizes fluid and cellular movements across the different
barriers of the brain compartments (blood, interstitial fluid, Virchow
Robin space, cerebrospinal fluid space comprising the cerebral
ventricles, basal cisterns and cortical subarachnoid space).
Aquaporins and other transporters control the fluid exchange at the
glial, endothelial, and choroid plexus barrier. At the glial, endothelial,
and pial barrier bi-directional flow may generate either a net in- or
outflux, providing fluid exchange rates, which surpass the net CSF
production rate by far. The choroid plexus is the only direct
connection between the blood and the CSF compartment. Major
portions of brain water are drained into the cervical lymphatics
from the VRS (including its capillary section) via intramural arterial
pathways (asterisks) and from the CSF space (via perineural
subarachnoid space of cranial nerves). The capillary and venular
endothelium may contribute to brain water absorption. Blood borne
inflammatory cells may enter the brain via VRS venules or via CP.
Fluid movements at the barriers are driven by osmotic and
hydrostatic gradients or by active transporter processes. Fluid
movements into and out of the VRS depend on respiratory and
cardiac pressure pulsations.
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glial and ependymal cell layers, may control brain water
movement around the Virchow Robin space and across
the brain compartments.
Magnetic resonance flow studies
Phase-contrast magnetic resonance imaging (MRI) can
provide quantitative blood flow velocity information in
humans [146]. It was applied to the study of CSF flow
along the aqueduct, a small canal connecting the third
and fourth cerebral ventricles [147,148]. Advanced phase-
contrast MRI, the cine phase-contrast technique yields
quantitative flow information by synchronizing the acqui-
sition of the images to the cardiac cycle [149]. Eventually,
these MRI techniques may be applied to assess the heart-
beat related stroke volume of CSF, from which the CSF
net flow along the aqueduct may be calculated [150].
Applying these techniques, the normal aqueduct flow has
been measured many times in adults with flow ratesranging from 0.304 to 1.2 ml min−1 [151-155]. Based upon
these data, the average normal flow in healthy adults was
suggested to be 0.77 ml min−1 in the craniocaudal direc-
tion [7]. Hence, CSF flow measured by MRI exceeds the
customarily assumed choroidal CSF production rate by
two fold. Findings showing a reversed (caudocranial) flow
of CSF along the aqueduct are even more puzzling. A
reversed flow of 0.41 ± 0.51 ml min−1 was reported in chil-
dren younger than two years [7]. Furthermore, a reversed
flow was reported in adult patients suffering from normal
pressure hydrocephalus: mean stroke volume in the con-
trol group was 30.1 ± 19.8 μl/cycle (craniocaudal direc-
tion), while that in the NPH group it was −63.2 ± 49.0 μl/
cycle (caudocranial direction) [156]. In NPH patients,
similar observations were reported by others [152]. Tech-
nical limitations of the MRI flow measurements must be
considered before interpreting these MRI data that are not
congruent with the traditional understanding of CSF
physiology. Thus it was pointed out that the evaluation of
the flow void is subjective and highly dependent on the
acquisition parameters used, as well as on the technical
characteristics of the MR imaging systems (e.g. gradient
strength) [147]. Unfortunately, there is no class A evi-
dence reported, which would clarify these conflicting data.
Appropriate clinical studies would be important. Also,
MRI techniques may be used to study interstitial water
movement: diffusion-weighted MRI provides a quantita-
tive parameter, i.e. the apparent diffusion coefficient
(ADC), which is thought to reflect water mobility in brain
tissues. Applying this technique it was shown in the rat
brain that reducing AQP4 protein expression with small
interfering RNAs (siRNAs) by 27% caused a 50% decrease
of the ADC [157].
Current research
There are numerous limitations of the early experiments
that form our classical understanding of CSF physiology.
Recent progress in neuroanatomy, molecular and cellular
biology, and neuroimaging challenge the traditional mo-
del. The pillars of the classical model, i.e. CSF production
at the choroid plexus, directed bulk flow and absorption
across the arachnoid villi are currently being questioned.
More recent experimental and clinical data have caused a
growing number of researchers to reach the consensus
that ISF and CSF are mainly formed and reabsorbed
across the walls of CNS blood capillaries, which implies
that there is no need for a directed CSF circulation
from CP to the arachnoid villi. Eventually, a number of
“unequivocal” findings, often more than 100 years old and
still governing the customary understanding of CSF phy-
siology, must be revised [7,9,10,88,95,98,122,158,159].
However, the novel concepts are also challenged
mainly by the lack of validated supporting data. For
example, Klarica et al. failed to reproduce the historical
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was found along a plastic cannula introduced into the
aqueduct of cats [16]. Subsequent experiments demon-
strated that the CSF pressure is not increased during the
first hours after the occlusion of aqueduct of Sylvius
[160]. Since they furthermore showed that following its
intraventricular injection radioactive water is almost
completely absorbed in the ventricles and does not reach
the basal cisterns [145], they concluded that the choroid
plexus is not the major site of CSF production and that
no directed CSF circulation according to the classical
understanding exists. Instead they proposed a model
that assumes CSF production and absorption occurs at
the level of the capillaries [10]. Considering the existence
of CSF flow along the aqueduct as shown by MRI flow
studies, others recognized that a model assuming CSF
flow exclusively at the capillary bed is deficient [7]. Fur-
thermore the view of Klarica et al. that CSF production
and absorption just depend on hydrodynamic and os-
motic gradients is not substantiated by current cellular
and molecular biology findings. In fact, the proposed
model does not consider the complex regulation of
water movement between the brain compartments as
discussed above. Finally, as in the original experiments
of Dandy, the experiments of Klarica et al. may be criti-
cized since they are surgically invasive and therefore re-
sults should be interpreted cautiously.
There are similar concerns with the most recent publi-
cations of Nedergaard and her group. In a series of experi-
ments, fluorescent tracers of different molecular weight
were injected into the cisterna magna of mice [95]. Ap-
plying two-photon laser scanning microscopy through a
closed cranial window, the distribution of tracers could be
observed 60–120 μm below the cortical surface. The ex-
periments showed a rapid increase of fluorescence within
the Virchow Robin space around the arterioles. Fluo-
rescent tracer was subsequently found within the brain
interstitium and later around the venules. Histological
examination 30 minutes after cisternal fluorescent tracer
injection revealed that larger molecular tracer (FITC-
d2000, 2000 kD) was confined to the VRS, while smaller
molecular weight tracer (TR-d3, 3 kD) was concentrated
in the VRS and also entered the interstitium. Investigating
AQP4-deficient mice with the same experimental tech-
niques, the authors found significantly less fluorescence
within both, the VRS around the arteries and in the brain
interstitium [95]. Considering the temporospatial occur-
rence of fluorescence, the authors deduced the existence
of a directed flow of CSF from the subarachnoid space
along the arteries and arterioles into the VRS, from here
into the brain interstitium, and finally from the brain into
the VRS around the venous vessels. Since the authors
showed in AQP4 deficient mice that, following its intersti-
tial injection, the clearance of soluble amyloid beta wassignificantly reduced, they concluded to have discovered
an unknown system for the clearing of interstitial protein
waste [88,161]. Assuming the PVS to serve as lymphatics
of the brain (a notion which was conceptualized already in
1968 by Foldi [162]) and considering the involvement of
astrocytes and their aquaporins the authors coined the
term “glymphatics” to describe the system [95].
It should be noted that the glymphatic concept as-
sumes transport from the SAS INTO the parenchyma
along periarterial pathways. This notion is supported
by previous findings of Rennels et al. [73]. However,
as already discussed above, especially the work of the
groups of Cserr [94] and Weller [45,70] support the view
that the periarterial flow provides a drainage OUT of the
parenchyma. Furthermore the findings of Nedergaard’s
group are not consistent with previous work applying
real-time video-densiometric techniques. Such experi-
ments have depicted the movement of tracers within the
VRS to be sluggish and the direction of flow varying in
an unpredictable manner [71]. Currently, it is difficult to
come to final conclusions about the direction of perivas-
cular CSF flow. This is a complex research topic with
difficult, technically challenging experiments not easily
replicated among the different groups.
Regarding the glymphatic concept, one may criticize
that it is based on two-photon laser scanning micros-
copy applying a 1 min scan time, which was optimized
to acquire a 240 μm stack at 20 μm intervals. This ap-
pears to be a limitation of the scanning technique in
terms of temporal resolution. It seems important to pro-
vide data with higher frequency imaging to clarify the
direction of perivascular flow [71]. Furthermore, with
the published data, it can’t be excluded that the observed
fluorescence around subarachnoid arteries may reflect
the nonspecific binding of dextran to the basement
membranes of arteries [87]. Considering these criticisms
and the point that the glymphatic concept represents a
fundamental revision of the current understanding of
CSF physiology, we feel that the concept needs to be
substantiated by comprehensive ultrastructural investi-
gations. Also studies in other species are warranted.
A subsequent publication of Nedergaard’s group re-
ports the exciting possibility of an increased clearance
rate of brain waste along the glymphatic pathway during
sleep [163]. This conclusion was derived from in vivo
two-photon laser scanning microscopy, fluorescent mi-
croscopy and measurements of the ISF volume compa-
ring awake, asleep and anaesthesized animals. However,
again, this is a very complex study design possibly prone
to experimental errors: investigating animals with mul-
tiple brain catheters and fixated in a stereotactic or
microscopic holder, one may assume that awake animals
are under massive stress and may fell asleep just because
of exhaustion. Although microdialysis was used to
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levels and norepinephrine did not increase in the experi-
ments, important stress parameters may differ between
the experimental groups, i.e. arterial blood pressure, ven-
ous blood pressure, stress hormone blood levels, heart
and respiratory rate and blood gases. The fact that none
of these parameters was recorded during the experi-
ments is a major drawback, since each of the parameters
may alter cerebral blood flow, cerebral blood volume,
intracranial pressure and even the perivascular pump
[79]. Each of these parameters may in turn influence ISF
and CSF circulation and the width of the interstitial
space.
In spite of this criticism, the observation that astro-
cytes are involved in the clearance of interstitial waste
molecules including soluble amyloid is exciting. In this
regard the experiments of Iliff et al. [95] revive the work
of Cserr [30], who showed that bulk flow mechanisms
contribute to the clearance of tracers injected into the
brain interstitium. Confirmatory evidence of the impact
of aquaporins on ISF regulation has been independently
reported by others [115].
Conclusions
The new findings do not render all of the previous,
sometimes historical, work invalid. However, CSF re-
searchers and clinicians have to recognize that much of
the earlier findings need to be re-interpreted.
For example, the discovery of aquaporins and other
water transporters, all highly selective just for water
molecules, implies that the extent of water exchange
across the barriers may be heavily underestimated by the
classical flow studies [30,49]. The tracers, used in the
classical experiments, were always larger than water
molecules and therefore could not be a substrate for the
water transporters. Also, the notion that osmolality does
not impact CSF absorption [2,33] or that CSF absorption
into capillaries requires a hydraulic pressure gradient,
which would cause the collapse of the vessel [47], needs
to be reconsidered. Even more puzzling, the notion of
directed bulk flow movement of CSF, i.e. flow from the
choroid plexus into the ventricles and along the cisterns
and the subarachnoid space across the arachnoid villi
back into the blood, must be questioned. As already sug-
gested by others [9,164], the novel findings indicate that
CSF circulation is much more complex, a combination
of directed bulk flow, pulsatile to and fro movement,
and continuous bi-directional fluid exchange at the
blood brain barrier and the cell membranes at the bor-
ders between CSF and ISF spaces. Ongoing research em-
phasizes the role of lymphatic pathways for the drainage
of ISF and CSF [45]; the observation that astrocytes and
their aquaporins drive lymphatic drainage may open a
new field of research [95]. The new insights into thephysiology of CSF circulation may have important cli-
nical relevance for example for the understanding of
neurodegenerative and immunological diseases of the
brain [45,161]. Also, opposing the classical view that
drugs injected into the CSF space will be washed out
within short time without targeting the brain [5], recent
findings demonstrate that drugs, following intrathecal
application, may very well be transported throughout
the entire brain [165].
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